[1]
L. Puig, M. Dossenbach, L. Berggren, A. Ljungberg, and C. Zachariae, “Absolute and Relative Psoriasis Area and Severity Indices (PASI) for Comparison of the Efficacy of Ixekizumab to Etanercept and Placebo in Patients with Moderate-to-severe Plaque Psoriasis: An Integrated Analysis of UNCOVER-2 and UNCOVER-3 Outcomes”, Acta Derm Venereol, vol. 99, no. 11, pp. 971–977, Aug. 2019.